GLP-1 Weight Loss
Tirzepatide
A dual-agonist GLP-1 / GIP program designed for patients seeking advanced metabolic results under provider direction with flat-rate pricing.
Available by consultation · $0 if not approved

Why it works
How Tirzepatide works
The first medication in its class to engage two metabolic pathways simultaneously — and the reason its trial outcomes set a new ceiling.
- Engages two metabolic pathways simultaneously
- Highest average weight loss recorded in published GLP-1-class trials
- Strong, monitored response profile under provider direction
How it works
Engages the GIP receptor
Targets glucose-dependent insulinotropic polypeptide — a metabolic pathway most weight-management medications do not address.
Engages the GLP-1 receptor
Simultaneously mimics GLP-1 — suppressing appetite and slowing how quickly food leaves the stomach.
Combined metabolic effect
The dual mechanism produces the highest average weight loss recorded in any GLP-1-class clinical trial to date.
What to expect
What to Expect
Tirzepatide tends to act faster and reach further than single-agonist GLP-1s. Your provider titrates carefully to the dose that fits your body.
Month 1
Titration
Faster initial response than single-agonist GLP-1s. Careful dose escalation begins.
Month 3
Established
Therapeutic dose reached. Strong metabolic momentum; appetite consistently reduced.
Month 6
~20%
Average body weight reduction in published trials. Many members exceed this range.
Year 1+
Sustained
Sustained reduction for the majority of members who remain in the program.
Outcomes referenced from SURMOUNT-1 trial data. Individual results depend on starting weight, dose, and adherence.
Safety first
Common side effects
Most common during titration: nausea, decreased appetite, and digestive changes. Typically mild and resolve as the body adjusts to each step in the protocol.
Who it’s not for
Not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2, or for patients who are pregnant or breastfeeding. Full medical history is reviewed before any prescription is authorized.
PAVE protocols are prepared by partner compounding pharmacies in the United States. Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine since long before mass-manufactured drugs existed. The active ingredient is prepared per your protocol — supervised by your provider — and delivered direct to your door.
Good to know
Every program begins with an online consultation. If your provider authorizes treatment, your protocol is prepared by a partner compounding pharmacy and delivered direct to your door, with structured check-ins and direct messaging access to your provider throughout.
We believe in complete transparency. Our programs feature flat-rate pricing with zero hidden fees, zero consultation charges, and no dose-change surcharges. The price we quote is the price you pay, period.
PAVE Health & Wellness is a brick-and-mortar clinic in Shafer, Minnesota. Our GLP-1 weight-loss programs are reviewed and supervised online via telehealth, while body contouring, IV therapy, and cryotherapy are offered in person at the clinic.
Your consultation is reviewed and authorized by a licensed provider. Every patient receives consistent, licensed clinical care with direct messaging access.
Memberships may be canceled with 30 days' notice prior to the next billing cycle. Consultations, medical visits, and fulfilled prescriptions are non-refundable once services begin or medication is processed.
Yes. PAVE is HIPAA compliant. Your medical information is shared only with your assigned provider and the dispensing pharmacy. We never sell or share your data.
Start your Tirzepatide plan.
A few minutes online, reviewed by a licensed provider. You’re only charged if it’s right for you.